Cell Source Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cell Source.
Cell Source Overview
About Cell Source
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched as well as mismatched organ transplantation.
Founded
2012
HQ
Employees
0
Website
Financials (FY)
EV
$51M
Valuation Multiples
Start free trial
Cell Source Financials
Cell Source reported last fiscal year revenue of - and negative EBITDA of ($3M).
In the same fiscal year, Cell Source generated ($3M) in EBITDA losses and had net loss of ($5M).
Cell Source P&L
In the most recent fiscal year, Cell Source reported revenue of - and EBITDA of ($3M).
Cell Source is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Cell Source Stock Performance
Cell Source has current market cap of $41M, and enterprise value of $51M.
Cell Source's stock price is $0.61.
Cell Source has an EPS (earnings per share) of $-0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $51M | $41M | 4.3% | - | - | - | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCell Source Valuation Multiples
Cell Source trades at (14.9x) EV/EBITDA.
Cell Source Financial Valuation Multiples
As of August 14, 2026, Cell Source has market cap of $41M and EV of $51M.
Cell Source has a P/E ratio of (9.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cell Source Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cell Source Margins & Growth Rates
Cell Source Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cell Source Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Cell Source competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cell Source
| When was Cell Source founded? | Cell Source was founded in 2012. |
| Where is Cell Source headquartered? | Cell Source is headquartered in United States. |
| How many employees does Cell Source have? | As of today, Cell Source has over 0 employees. |
| Is Cell Source publicly listed? | Yes, Cell Source is a public company listed on OTCM. |
| What is the stock symbol of Cell Source? | Cell Source trades under CLCS ticker. |
| When did Cell Source go public? | Cell Source went public in 2014. |
| Who are competitors of Cell Source? | Cell Source main competitors include |
| What is the current market cap of Cell Source? | Cell Source's current market cap is $41M. |
| Is Cell Source profitable? | No, Cell Source is not profitable. |
| How many companies Cell Source has acquired to date? | Cell Source hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Cell Source has invested to date? | Cell Source hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Cell Source
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.